Kenvue Inc (KVUE)

$19.83 +0.50 (2.59%)
Market Cap 38.07B
Revenue (ttm) 15.12B
Net Income (ttm) 1.47B
EPS (ttm) N/A
PE Ratio 16.66
Forward PE 16.68
Profit Margin 9.72%
Debt to Equity Ratio 0.67
Volume 11,433,500
Avg Vol 20,614,148
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 98%
Beta 0.47
Analysts Sell
Price Target $19.00

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and bod...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 908 874 1200
Address:
1 Kenvue Way, Summit, United States
Latest News on KVUE
Kimberly-Clark price target raised to $121 from $115 at Piper Sandler

2026-06-17T10:40:09.000Z - 17 days ago

Kimberly-Clark price target raised to $121 from $115 at Piper Sandler

KMB

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

Jun 3, 2026, 8:10 AM EDT - 4 weeks ago

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

AES ARW BAX EXP EXPD HPQ IESC

Kenvue Transcript: AGM 2026

May 21, 2026, 9:00 AM EDT - 6 weeks ago

Kenvue Transcript: AGM 2026

Kenvue Earnings release: Q1 2026

May 7, 2026, 9:30 AM EDT - 2 months ago

Kenvue Earnings release: Q1 2026

Kenvue Quarterly report: Q1 2026

May 7, 2026, 9:30 AM EDT - 2 months ago

Kenvue Quarterly report: Q1 2026

Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark

May 7, 2026, 7:15 AM EDT - 2 months ago

Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark

KMB

Kenvue reports Q1 adjusted EPS 32c, consensus 26c

2026-05-07T11:12:08.000Z - 2 months ago

Kenvue reports Q1 adjusted EPS 32c, consensus 26c

Kenvue Reports First Quarter 2026 Results

May 7, 2026, 6:30 AM EDT - 2 months ago

Kenvue Reports First Quarter 2026 Results

Kenvue Declares Quarterly Cash Dividend

Apr 29, 2026, 6:45 AM EDT - 2 months ago

Kenvue Declares Quarterly Cash Dividend

This 5-Stock “Super Staples” Portfolio Yields Up To 11.3%

Apr 26, 2026, 9:40 AM EDT - 2 months ago

This 5-Stock “Super Staples” Portfolio Yields Up To 11.3%

CAG CALM FLO KMB NOMD

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Apr 23, 2026, 4:32 PM EDT - 2 months ago

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

Apr 15, 2026, 10:01 AM EDT - 2 months ago

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

KMB

Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal

Apr 15, 2026, 9:52 AM EDT - 2 months ago

Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal

KMB

Kimberly-Clark announces organizational structure after acquisition of Kenvue

2026-04-15T13:04:56.000Z - 2 months ago

Kimberly-Clark announces organizational structure after acquisition of Kenvue

KMB

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

Apr 15, 2026, 8:55 AM EDT - 2 months ago

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

KMB

Kenvue price target lowered to $19 from $20 at Citi

2026-04-15T10:40:06.000Z - 2 months ago

Kenvue price target lowered to $19 from $20 at Citi

Kenvue price target lowered to $18 from $19 at Barclays

2026-04-14T13:08:51.000Z - 2 months ago

Kenvue price target lowered to $18 from $19 at Barclays

Tylenol in pregnancy not linked with autism, Danish study finds

Apr 13, 2026, 2:09 PM EDT - 2 months ago

Tylenol in pregnancy not linked with autism, Danish study finds

Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Kenvue Proxy statement: Proxy filing

Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Kenvue Proxy statement: Proxy filing

Kenvue price target lowered to $18 from $19 at UBS

2026-04-07T11:09:21.000Z - 3 months ago

Kenvue price target lowered to $18 from $19 at UBS

Tylenol use among women dropped after Trump tied it to autism

Mar 6, 2026, 12:43 PM EST - 4 months ago

Tylenol use among women dropped after Trump tied it to autism

Kenvue price target raised to $19 from $18 at Barclays

2026-03-06T10:52:41.000Z - 4 months ago

Kenvue price target raised to $19 from $18 at Barclays

Judge spurns Kenvue bid to dismiss Texas lawsuit over Tylenol, Reuters reports

2026-02-26T17:20:12.000Z - 4 months ago

Judge spurns Kenvue bid to dismiss Texas lawsuit over Tylenol, Reuters reports

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Feb 26, 2026, 11:14 AM EST - 4 months ago

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Kenvue rumor highlighted in Betaville blog

2026-02-20T20:31:01.000Z - 4 months ago

Kenvue rumor highlighted in Betaville blog

Kenvue price target raised to $19 from $17 at UBS

2026-02-18T12:46:01.000Z - 4 months ago

Kenvue price target raised to $19 from $17 at UBS

Kenvue price target raised to $18 from $17 at Canaccord

2026-02-18T12:17:16.000Z - 4 months ago

Kenvue price target raised to $18 from $17 at Canaccord

Kenvue price target raised to $20 from $18 at Citi

2026-02-18T11:35:35.000Z - 4 months ago

Kenvue price target raised to $20 from $18 at Citi

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Feb 17, 2026, 5:50 PM EST - 4 months ago

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

Feb 17, 2026, 5:42 PM EST - 4 months ago

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

KMB

Kenvue reports Q4 EPS 27c, consensus 22c

2026-02-17T21:50:45.000Z - 4 months ago

Kenvue reports Q4 EPS 27c, consensus 22c

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Feb 17, 2026, 4:45 PM EST - 4 months ago

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Kenvue Annual report: Q4 2025

Feb 17, 2026, 4:00 PM EST - 4 months ago

Kenvue Annual report: Q4 2025

Kenvue Earnings release: Q4 2025

Feb 17, 2026, 4:00 PM EST - 4 months ago

Kenvue Earnings release: Q4 2025

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Feb 4, 2026, 6:45 AM EST - 5 months ago

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

Jan 29, 2026, 9:27 AM EST - 5 months ago

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

KMB

Kenvue Transcript: AGM 2026

Jan 29, 2026, 9:00 AM EST - 5 months ago

Kenvue Transcript: AGM 2026

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

Jan 27, 2026, 6:40 AM EST - 5 months ago

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

KMB

Paracetamol/Tylenol in pregnancy is safe, says research prompted by Trump autism claims

Jan 16, 2026, 6:32 PM EST - 6 months ago

Paracetamol/Tylenol in pregnancy is safe, says research prompted by Trump autism claims

ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

Jan 16, 2026, 10:00 AM EST - 6 months ago

ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

KMB

Kenvue Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 7 months ago

Kenvue Proxy statement: Proxy Filing

US appeals court to weigh reviving cases over Tylenol and autism

Nov 17, 2025, 6:07 AM EST - 8 months ago

US appeals court to weigh reviving cases over Tylenol and autism

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Nov 14, 2025, 12:42 PM EST - 8 months ago

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Nov 14, 2025, 6:05 AM EST - 8 months ago

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 8 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

Nov 3, 2025, 10:00 PM EST - 8 months ago

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

KMB

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

Nov 3, 2025, 7:11 PM EST - 8 months ago

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

KMB

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Nov 3, 2025, 6:40 PM EST - 8 months ago

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

KMB

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

Nov 3, 2025, 5:20 PM EST - 8 months ago

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

KMB

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

Nov 3, 2025, 5:15 PM EST - 8 months ago

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

AMZN KMB

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

Nov 3, 2025, 4:58 PM EST - 8 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

KMB

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

Nov 3, 2025, 4:39 PM EST - 8 months ago

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

KMB

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

Nov 3, 2025, 4:01 PM EST - 8 months ago

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

KMB

Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 8 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

Nov 3, 2025, 12:37 PM EST - 8 months ago

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

KMB

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Nov 3, 2025, 12:01 PM EST - 8 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

KMB

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

Nov 3, 2025, 11:40 AM EST - 8 months ago

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

KMB

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

Nov 3, 2025, 11:18 AM EST - 8 months ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KMB

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Nov 3, 2025, 10:44 AM EST - 8 months ago

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

KMB

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

Nov 3, 2025, 10:33 AM EST - 8 months ago

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

KMB

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

Nov 3, 2025, 9:57 AM EST - 8 months ago

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

KMB

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Nov 3, 2025, 9:30 AM EST - 8 months ago

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Nov 3, 2025, 9:16 AM EST - 8 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

KMB

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

Nov 3, 2025, 9:15 AM EST - 8 months ago

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

KMB

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

Nov 3, 2025, 8:40 AM EST - 8 months ago

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

KMB

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

Nov 3, 2025, 8:27 AM EST - 8 months ago

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

KMB

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

Nov 3, 2025, 8:24 AM EST - 8 months ago

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

KMB